# Urogen Pharma Ltd. (URGN) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$125M |
| 2024 | -$97M |
| 2023 | -$66M |
| 2022 | -$79M |
| 2021 | -$92M |
| 2020 | -$127M |
| 2019 | -$109M |
| 2018 | -$77M |
| 2017 | -$20M |
| 2016 | $798,000 |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$20M |
| 2025-09-30 | -$27M |
| 2025-06-30 | -$41M |
| 2025-03-31 | -$37M |
| 2024-09-30 | -$18M |
| 2024-06-30 | -$26M |
| 2024-03-31 | -$26M |
| 2023-09-30 | -$14M |
| 2023-06-30 | -$15M |
| 2023-03-31 | -$22M |
| 2022-09-30 | -$18M |
| 2022-06-30 | -$19M |
| 2022-03-31 | -$22M |
| 2021-09-30 | -$23M |
| 2021-06-30 | -$23M |
| 2021-03-31 | -$26M |
| 2020-09-30 | -$29M |
| 2020-06-30 | -$32M |
| 2019-06-30 | -$24M |
| 2018-09-30 | -$21M |
| 2018-06-30 | -$18M |
| 2018-03-31 | -$14M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/URGN/operating-income)